A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
German Cancer Research Center · Heidelberg University · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
221
total citations
- FWCI
- 47.98
- Percentile
- 100%
- References
- 53
Citations per year
Authors
49- CKChristoph K. Stein‐Thoeringer
German Cancer Research Center, Heidelberg University, STZ eyetrial, University of Tübingen
- NSNeeraj SainiCorresponding
The University of Texas MD Anderson Cancer Center
- EZEli Zamir
German Cancer Research Center, Heidelberg University
- VBViktoria Blumenberg
German Cancer Research Center, LMU Klinikum, Ludwig-Maximilians-Universität München
- MSMaria‐Luisa Schubert
Heidelberg University, University Hospital Heidelberg
Topics & keywords
Keywords
- Akkermansia
- Microbiome
- Antibiotics
- Immunology
- Medicine
- Cancer
- Cohort
- Population
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- HHHoward Hughes Medical Institute
- BABill and Melinda Gates Foundation
- IDInfectious Diseases Society of America
- CICanadian Institute for Advanced Research
- BSBaden-Württemberg Stiftung
- DKDeutsches Krebsforschungszentrum
- WSWilhelm Sander-StiftungAward: 2021.040.1
- MCMoffitt Cancer CenterAwards: P30 CA076292, CA076292
- WTWellcome Trust
- IFIDSA Foundation
- DFDeutsche ForschungsgemeinschaftAwards: TRR221, SFB1335, SFB1371, EXC-2124, 360372040, 324392634, 395357507
- UHUniversität Heidelberg
- WIWeizmann Institute of Science
- DKDeutsche KrebshilfeAward: 70114547
- MOMinistry of Science and Technology, Israel
- NCNationales Centrum für Tumorerkrankungen Heidelberg
- DKDeutschen Konsortium für Translationale Krebsforschung
- NCNational Cancer InstituteAwards: CA076292, P30 CA076292, P30CA016672